Bosutinib Sandoz 100 mg
Bosutinib Sandoz 100 mg is a medicine authorised by Swissmedic under authorisation number 69145. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 04 June 2024 and the authorisation is limited until 03 June 2029. ATC code L01EA04 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69145 |
|---|---|
| Name | Bosutinib Sandoz 100 mg |
| Full name | Bosutinib Sandoz 100 mg, Filmtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EA04 |
| First authorisation | 04 June 2024 |
| Authorisation validity | 03 June 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bosutinib Sandoz 100 mg, Filmtabletten | A | 04 June 2024 |
| 2 | Bosutinib Sandoz 400 mg, Filmtabletten | A | 04 June 2024 |
| 3 | Bosutinib Sandoz 500 mg, Filmtabletten | A | 04 June 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | L01EA04 | 07.16.1. | A |
| 2 | 28 | Tablette(n) | L01EA04 | 07.16.1. | A |
| 3 | 28 | Tablette(n) | L01EA04 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bosutinib Sandoz 100 mg authorised in Switzerland?
Yes. Bosutinib Sandoz 100 mg is authorised by Swissmedic under authorisation number 69145, data as of 01 September 2026. The authorisation is limited until 03 June 2029.
Which dispensing category does Bosutinib Sandoz 100 mg have?
Bosutinib Sandoz 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Bosutinib Sandoz 100 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.